| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP & Amp; Bu Lead - Infectious | EVP & Bu Lead - Infectious | EVP - Infectious Diseases +1 more
1 company
Anthony Zezzo II last filed a Form 4 in February 2020, as EVP & Amp; Bu Lead - Infectious at OSUR. Anthony Zezzo II's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 227,867 shares of OSUR. The OSUR filings lean toward selling, a net 187,916 shares.
Anthony Zezzo II has 11 Form 4 filings on record from February 2015 to February 2020, all as EVP & Amp; Bu Lead - Infectious at Orasure Technologies (OSUR), 2015–2020.
The 33 reported transactions were 18 tax withholdings, 10 stock awards, 2 option exercises and 2 open-market sales, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $3.2M.
The largest open-market sale was 115,000 shares of OSUR at an average $14.70 on May 10, 2017, about $1.7M.
Shares as reported in the last Form 4 for each company; the most recent is from February 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.